Indonesian pharmaceutical products have been received by European Union (EU) countries and have also entered the Asian market such as the Cambodian market and even this market is very promising for these products with a significant increase because the quality is already known, and the price is affordable. Various facilities provided by the Indonesian government to encourage the growth of the upstream pharmaceutical industry to meet the needs of the downstream industry, which have so far been mostly imported. Government regulations and health assistance projects from international institutions have also contributed significantly to the development of the pharmaceutical industry.
The Food and Drug Supervisory Agency (BPOM) is optimistic that the Indonesian pharmaceutical industry has enormous potential and Indonesia is no longer a country left behind in terms of medicines. In fact, Indonesia has been very capable of supplying the needs of other countries, especially for vaccines and medicines to member countries of the Organization of Islamic Cooperation (OIC).
Indonesia currently has international quality pharmaceutical products but is not well-known in the international market. Indonesian pharmaceutical products already have a very well-maintained standard, both in terms of quality, safety and efficacy of medicines, so that Indonesian-produced medicines do not need to worry about being able to compete in the global market.
Indonesia as one of the two Organization of Islamic Cooperation (OIC) countries that received qualified drug certificates from the World Health Organization (WHO) has enormous potential in supplying drugs and vaccines to OIC countries. The country that received the certification was only Senegal and Indonesia. Senegal only gets 1 Vaccine certificate, while Indonesia has more than 10 certificates of medicine.
Indonesia is the second richest country in the world in terms of biodiversity. There are around 30,000 species identified and 950 species of which are known to have biopharmaceutical functions, namely plants, animals, and microbes that have potential as drugs, health food, nutraceuticals, both for humans, animals, and plants. Indonesia has a supply of pharmaceutical products that can meet world demand, this can be seen from Indonesia’s exports of HS code 30 (Drug Products) to the world.
